242 related articles for article (PubMed ID: 18972344)
1. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
Benjaminsen IC; Melås EA; Mathiesen BS; Rofstad EK
J Magn Reson Imaging; 2008 Nov; 28(5):1209-18. PubMed ID: 18972344
[TBL] [Abstract][Full Text] [Related]
2. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.
Gaustad JV; Benjaminsen IC; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2007 Jul; 26(1):133-43. PubMed ID: 17659570
[TBL] [Abstract][Full Text] [Related]
5. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
Gulliksrud K; Brurberg KG; Rofstad EK
Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
[TBL] [Abstract][Full Text] [Related]
7. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
[TBL] [Abstract][Full Text] [Related]
8. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
10. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
[TBL] [Abstract][Full Text] [Related]
12. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Vestvik IK; Benjaminsen IC; Mathiesen B; Rofstad EK
Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
[TBL] [Abstract][Full Text] [Related]
13. Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Benjaminsen IC; Hedalen K; Mathiesen B; Rofstad EK
Radiat Res; 2008 Jun; 169(6):689-99. PubMed ID: 18494552
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI.
Brurberg KG; Benjaminsen IC; Dørum LM; Rofstad EK
Magn Reson Med; 2007 Sep; 58(3):473-81. PubMed ID: 17763357
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.
Benjaminsen IC; Graff BA; Brurberg KG; Rofstad EK
Magn Reson Med; 2004 Aug; 52(2):269-76. PubMed ID: 15282808
[TBL] [Abstract][Full Text] [Related]
17. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
Rofstad EK; Galappathi K; Mathiesen B; Ruud EB
Clin Cancer Res; 2007 Apr; 13(7):1971-8. PubMed ID: 17360973
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced-MRI of tumor hypoxia.
Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Magn Reson Med; 2012 Feb; 67(2):519-30. PubMed ID: 21661044
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
20. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.
Gulliksrud K; Vestvik IK; Galappathi K; Mathiesen B; Rofstad EK
Radiat Res; 2008 Nov; 170(5):638-50. PubMed ID: 18959463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
